NASDAQ:FTXH First Trust Nasdaq Pharmaceuticals ETF (FTXH) Price, Holdings, & News $40.47 -0.05 (-0.12%) Closing price 09/11/2026 03:59 PM EasternExtended Trading$40.44 -0.02 (-0.06%) As of 09/11/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort Interest About First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get FTXH alerts:Sign Up Key Stats Today's Range$40.41▼$40.8650-Day Range$37.76▼$42.7652-Week Range$27.30▼$42.87Volume20,380 shsAverage Volume223,786 shsMarket Capitalization$953.07 millionAssets Under ManagementN/ADividend Yield1.04%Net Expense Ratio0.60%Aggregate RatingModerate Buy ETF Overview The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust. Read More First Trust Nasdaq Pharmaceuticals ETF ExpensesTypeFTXHHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.60%0.55%0.57%0.54%0.53%Other Expenses0.00%0.52%0.53%0.38%0.54%Total Expense0.60%0.76%0.75%0.69%0.73%Fee Waiver0.00%-0.85%-0.67%-0.41%-0.68%Net Expense0.60%0.58%0.63%0.61%0.60% Receive FTXH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for First Trust Nasdaq Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. FTXH ETF News HeadlinesTrump to announce discount drug pricing expansion, White House official saysMay 18, 2026 | reuters.comFirst Trust Nasdaq BuyWrite Income ETF declares $0.207 dividendJanuary 22, 2025 | msn.comPrint this before your next tradeBill Poulos is offering his Smart Trade Options Checklist at no cost today - normally priced at $29.97. It's a single-page, seven-point filter designed to help traders identify weak setups before placing any options trade. Print it, keep it at your desk, and run it before every trade. The download link expires soon.September 12 at 1:00 AM | Profits Run (Ad)3 Health Care ETFs You'll Want to Own When the Market RecoversAugust 3, 2022 | stocknews.comSurprising Analyst 12-Month Target For FTXHMay 25, 2022 | nasdaq.comFirst Trust Nasdaq Pharmaceuticals ETF declares quarterly distribution of $0.0488March 25, 2022 | seekingalpha.comSee More Headlines FTXH ETF - Frequently Asked Questions How have FTXH shares performed this year? First Trust Nasdaq Pharmaceuticals ETF's stock was trading at $32.9960 at the start of the year. Since then, FTXH shares have increased by 22.7% and is now trading at $40.47. Who are First Trust Nasdaq Pharmaceuticals ETF's major shareholders? Top institutional shareholders of First Trust Nasdaq Pharmaceuticals ETF include Nilsine Partners LLC (0.12%), Citadel Advisors LLC (0.03%) and Compass Financial Management LLC. How do I buy shares of First Trust Nasdaq Pharmaceuticals ETF? Shares of FTXH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of First Trust Nasdaq Pharmaceuticals ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that First Trust Nasdaq Pharmaceuticals ETF investors own include Cummins (CMI), Cannabis Wheaton Income (CBWTF), Biocorrx (BICX). Fund Details IssuerFirst Trust Fund NameFirst Trust Nasdaq Pharmaceuticals ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:FTXH Inception Date9/20/2016 Fund ManagerDaniel Lindquist, Jon Erickson, David McGarel, Roger Testin, Stan Ueland, Chris Peterson, Erik Russo WebN/A Phone14089961010Fund Focus Asset ClassEquity BenchmarkNasdaq US Smart Pharmaceuticals Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings50 Fund Statistics Assets Under Management$0.00 Average Daily Volume$90.84 thousand Discount/Premium0.00% Administrator, Advisor and Custodian AdministratorThe Bank of New York Mellon Corporation AdvisorFirst Trust Advisors L.P. CustodianThe Bank of New York Mellon Corporation DistributorFirst Trust Portfolios L.P. Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerOld Mission Options OptionableN/A Short Interest134,463 shs Miscellaneous Outstanding Shares23,550,000Beta0.46 Creation Unit50,000 Creation Fee$500.00 The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report Top 10 FTXH HoldingsEli Lilly and Company (NYSE:LLY)Holding Weight: 7.48%AbbVie (NYSE:ABBV)Holding Weight: 7.19%Johnson & Johnson (NYSE:JNJ)Holding Weight: 7.03%Merck & Co., Inc. (NYSE:MRK)Holding Weight: 7.03%Bristol Myers Squibb (NYSE:BMY)Holding Weight: 6.82%Biogen (NASDAQ:BIIB)Holding Weight: 3.57%Amgen (NASDAQ:AMGN)Holding Weight: 3.54%Viatris (NASDAQ:VTRS)Holding Weight: 3.49%Vertex Pharmaceuticals (NASDAQ:VRTX)Holding Weight: 3.43%Regeneron Pharmaceuticals (NASDAQ:REGN)Holding Weight: 3.35%Full Holdings DetailsFTXH Sector ExposureFTXH Industry Exposure This page (NASDAQ:FTXH) was last updated on 9/12/2026 by MarketBeat.com Staff. From Our PartnersWhy I'm NOT Buying the SpaceX IPO (And What I'm Buying Instead)Don't buy Nvidia... Not when the AI companies that will define the next decade are selling for pennies. You wo...Decentralized Masters | SponsoredPrint this before your next tradeBill Poulos is offering his Smart Trade Options Checklist at no cost today - normally priced at $29.97. It'...Profits Run | SponsoredMy ‘one day’ retirement secretTradeSmith's AI research team, backed by a $17 million investment and led by a former NSA codebreaker, built a...TradeSmith | SponsoredThis 38 Dollar Fund Holds Every Major AI Stock and Pays WeeklyThe biggest AI stocks like Nvidia, CrowdStrike, and Palantir now trade for hundreds of dollars a share. One fu...Investors Alley | SponsoredThe retirement stock I'd buy before Nvidia todayIn 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Ch...Chaikin Analytics | SponsoredWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | Sponsoredyour job is on the listThe CEO of one of the largest AI labs on earth said it plainly: AI could wipe out half of all entry-level whit...Behind the Markets | SponsoredThree companies about to leapfrog Nvidia [And transform the entire industry]Three under-the-radar companies are already building the infrastructure behind a 200 billion government-backed...Eagle Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust Nasdaq Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share First Trust Nasdaq Pharmaceuticals ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
